Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes.

<h4>Background and purpose</h4>Vocal fold leukoplakia, white plaque on the epithelium, has the potential for malignant transformation regardless of dysplasia grade. It is treated with different laser types (CO2 or angiolytic) and various techniques (vaporization, stripping, or excision);...

Full description

Bibliographic Details
Main Authors: Jae-Yol Lim, Young Min Park, Minsuk Kang, Seung Jin Lee, Kwangha Baek, Jina Na, Hong-Shik Choi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0209691
_version_ 1819140229281349632
author Jae-Yol Lim
Young Min Park
Minsuk Kang
Seung Jin Lee
Kwangha Baek
Jina Na
Hong-Shik Choi
author_facet Jae-Yol Lim
Young Min Park
Minsuk Kang
Seung Jin Lee
Kwangha Baek
Jina Na
Hong-Shik Choi
author_sort Jae-Yol Lim
collection DOAJ
description <h4>Background and purpose</h4>Vocal fold leukoplakia, white plaque on the epithelium, has the potential for malignant transformation regardless of dysplasia grade. It is treated with different laser types (CO2 or angiolytic) and various techniques (vaporization, stripping, or excision); however, only a few studies exist regarding comparative laser surgery results. This study was conducted to investigate clinical outcomes of CO2 versus angiolytic laser microdissection with regard to long-term disease control and voice preservation in vocal fold leukoplakia.<h4>Materials and methods</h4>Seventy patients with vocal fold leukoplakia treated by CO2 or angiolytic laser (pulsed dye laser or potassium titanyl phosphate) were identified retrospectively. Data regarding patient characteristics, treatment details, treatment outcomes including disease control (recurrence and progression) and the Voice Handicap Index, GRBAS scale, and acoustics were evaluated. The mean follow-up duration after initial treatment was 32 ± 26 months.<h4>Results</h4>The study group comprised 14 patients who underwent CO2 laser microflap excision and 56 who underwent angiolytic laser stripping. Of the patients treated with CO2 laser, 11 (79%) had no recurrence and three (21%) showed recurrent leukoplakia, of which one patient (7%) showed histologic grade progression. Of patients who underwent angiolytic laser stripping, 12 had disease recurrence (21%), among whom three (5%) showed disease progression. Laser surgery type, disease extent, and histologic grade showed no significant differences in recurrence or progression rates. The postoperative Voice Handicap Index significantly improved (P = .03) and the G score significantly decreased (P < .001) in the angiolytic laser treatment group. In contrast, the Voice Handicap Index increased postoperatively in the CO2 laser group (P = .046).<h4>Conclusions</h4>The long-term recurrence or progression rates were not significantly different between angiolytic and CO2 laser treatment. The angiolytic laser stripping group showed better voice preservation compared with the CO2 laser group. Angiolytic laser stripping is suggested as an effective treatment option for vocal fold leukoplakia with comparable disease control and better voice preservation.
first_indexed 2024-12-22T11:35:14Z
format Article
id doaj.art-24e681b8ec7643efbc87c7cf4646a6fb
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T11:35:14Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-24e681b8ec7643efbc87c7cf4646a6fb2022-12-21T18:27:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011312e020969110.1371/journal.pone.0209691Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes.Jae-Yol LimYoung Min ParkMinsuk KangSeung Jin LeeKwangha BaekJina NaHong-Shik Choi<h4>Background and purpose</h4>Vocal fold leukoplakia, white plaque on the epithelium, has the potential for malignant transformation regardless of dysplasia grade. It is treated with different laser types (CO2 or angiolytic) and various techniques (vaporization, stripping, or excision); however, only a few studies exist regarding comparative laser surgery results. This study was conducted to investigate clinical outcomes of CO2 versus angiolytic laser microdissection with regard to long-term disease control and voice preservation in vocal fold leukoplakia.<h4>Materials and methods</h4>Seventy patients with vocal fold leukoplakia treated by CO2 or angiolytic laser (pulsed dye laser or potassium titanyl phosphate) were identified retrospectively. Data regarding patient characteristics, treatment details, treatment outcomes including disease control (recurrence and progression) and the Voice Handicap Index, GRBAS scale, and acoustics were evaluated. The mean follow-up duration after initial treatment was 32 ± 26 months.<h4>Results</h4>The study group comprised 14 patients who underwent CO2 laser microflap excision and 56 who underwent angiolytic laser stripping. Of the patients treated with CO2 laser, 11 (79%) had no recurrence and three (21%) showed recurrent leukoplakia, of which one patient (7%) showed histologic grade progression. Of patients who underwent angiolytic laser stripping, 12 had disease recurrence (21%), among whom three (5%) showed disease progression. Laser surgery type, disease extent, and histologic grade showed no significant differences in recurrence or progression rates. The postoperative Voice Handicap Index significantly improved (P = .03) and the G score significantly decreased (P < .001) in the angiolytic laser treatment group. In contrast, the Voice Handicap Index increased postoperatively in the CO2 laser group (P = .046).<h4>Conclusions</h4>The long-term recurrence or progression rates were not significantly different between angiolytic and CO2 laser treatment. The angiolytic laser stripping group showed better voice preservation compared with the CO2 laser group. Angiolytic laser stripping is suggested as an effective treatment option for vocal fold leukoplakia with comparable disease control and better voice preservation.https://doi.org/10.1371/journal.pone.0209691
spellingShingle Jae-Yol Lim
Young Min Park
Minsuk Kang
Seung Jin Lee
Kwangha Baek
Jina Na
Hong-Shik Choi
Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes.
PLoS ONE
title Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes.
title_full Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes.
title_fullStr Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes.
title_full_unstemmed Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes.
title_short Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes.
title_sort angiolytic laser stripping versus co2 laser microflap excision for vocal fold leukoplakia long term disease control and voice outcomes
url https://doi.org/10.1371/journal.pone.0209691
work_keys_str_mv AT jaeyollim angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT youngminpark angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT minsukkang angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT seungjinlee angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT kwanghabaek angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT jinana angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes
AT hongshikchoi angiolyticlaserstrippingversusco2lasermicroflapexcisionforvocalfoldleukoplakialongtermdiseasecontrolandvoiceoutcomes